Vaccines and Guillain-Barré syndrome (Q34977408)

5 August 2017

1 reference

title

Vaccines and Guillain-Barré syndrome. (English)

1 reference

5 August 2017

Guillain–Barré syndrome

0 references

2

James Sejvar

1 reference

5 August 2017

4

Frank DeStefano

1 reference

5 August 2017

Penina Haber

1

1 reference

PubMed ID

19388722

5 August 2017

Yann Mikaeloff

series ordinal

3

1 reference

5 August 2017

1 January 2009

1 reference

5 August 2017

1 reference

5 August 2017

32

1 reference

5 August 2017

4

1 reference

5 August 2017

309-323

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-200932040-00005

5 August 2017

0 references

cites work

Neurologic complications of Semple-type rabies vaccine: clinical and immunologic studies

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200932040-00005

Immunologic studies of rabies vaccination-induced Guillain-Barré syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200932040-00005

Nationwide oral poliovirus vaccination campaign and the incidence of Guillain-Barré Syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200932040-00005

Epidemiologic study of Guillain-Barré syndrome in children <15 years of age in Latin America.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200932040-00005

Acute inflammatory demyelinating polyradiculoneuropathy (Guillain-Barré syndrome) after immunization with Haemophilus influenzae type b conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200932040-00005

Neurologic illness following post-exposure prophylaxis with purifiled chick embryo cell antirabies vaccine

21 January 2018

1 reference

12 December 2020

Efficacy and safety of a Haemophilus influenzae type b capsular polysaccharide-tetanus protein conjugate vaccine

1 reference

12 December 2020

Guillain-Barré Syndrome After Influenza Vaccination in Adults

1 reference

12 December 2020

Risk of Guillain-Barré syndrome following serogroup C meningococcal conjugate vaccine in Quebec, Canada

1 reference

12 December 2020

Guillain-Barre syndrome occurring after rabies vaccination.

1 reference

12 December 2020

Epidemiology of Guillain-Barré syndrome in children: relationship of oral polio vaccine administration to occurrence

1 reference

12 December 2020

Reassessment of the Association between Guillain-Barré Syndrome and Receipt of Swine Influenza Vaccine in 1976–1977: Results of a Two-State Study

1 reference

12 December 2020

Guillain-Barré syndrome following influenza vaccination

1 reference

12 December 2020

The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines.

1 reference

12 December 2020

The safety of hepatitis B virus vaccine.

1 reference

12 December 2020

Vaccine-associated paralytic poliomyelitis caused by contact infection

1 reference

12 December 2020

Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007.

1 reference

12 December 2020

Risk of Guillain-Barré syndrome after measles-mumps-rubella vaccination

1 reference

12 December 2020

Guillain-Barré syndrome in the United States, 1979-1980 and 1980-1981. Lack of an association with influenza vaccination

1 reference

12 December 2020

Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).

1 reference

12 December 2020

Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB): clinical evaluation

1 reference

12 December 2020

Guillain-Barré syndrome and human diploid cell rabies vaccine

1 reference

12 December 2020

Update: Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine--United States, June 2005-September 2006

1 reference

12 December 2020

HLA antigens in Guillain-Barré syndrome

1 reference

12 December 2020

Case reports, including one postvaccinal, of polyradiculoneuritis (Guillain-Barré syndrome in infancy.

1 reference

12 December 2020

Measles-mumps vaccination in the FRG: an empirical analysis after 14 years of use. II. Tolerability and analysis of spontaneously reported side effects

1 reference

12 December 2020

Guillain-Barré syndrome following hepatitis B vaccination.

1 reference

12 December 2020

Neurologic adverse events associated with smallpox vaccination in the United States, 2002-2004.

1 reference

12 December 2020

No Association Between Immunization and Guillain-Barré Syndrome in the United Kingdom, 1992 to 2000

1 reference

12 December 2020

Fas polymorphisms are associated with the presence of anti-ganglioside antibodies in Guillain-Barre syndrome

1 reference

12 December 2020

Guillain-Barré syndrome following administration of live measles vaccine

1 reference

12 December 2020

Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine--United States, June-July 2005

1 reference

12 December 2020

Clinical and epidemiologic features of Guillain-Barré syndrome

1 reference

12 December 2020

Yellow fever and Japanese encephalitis vaccines: indications and complications

1 reference

12 December 2020

Association between oral poliovaccine and Guillain-Barré syndrome?

1 reference

12 December 2020

Guillain-Barré syndrome associated with immunization against rabies: epidemiological aspects

1 reference

12 December 2020

Guillain-Barré syndrome: the swine influenza virus vaccine incident in the United States of America, 1976-77: preliminary communication

1 reference

12 December 2020

Risk of relapse of Guillain-Barré syndrome or chronic inflammatory demyelinating polyradiculoneuropathy following immunisation

1 reference

12 December 2020

[Guillain-Barré syndrome appearing after an antismallpox vaccination]

1 reference

12 December 2020

Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up

1 reference

12 December 2020

A distributed research network model for post-marketing safety studies: the Meningococcal Vaccine Study.

1 reference

12 December 2020

Possible association of Guillain-Barré syndrome and hepatitis A vaccination

1 reference

12 December 2020

Neurologic disease associated with 17D-204 yellow fever vaccination: a report of 15 cases.

1 reference

12 December 2020

Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977

1 reference

12 December 2020

Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy

1 reference

12 December 2020

Guillain-Barré syndrome and influenza vaccination in the US Army, 1980-1988.

1 reference

12 December 2020

Frequency of adverse reactions to hepatitis B vaccine in 43,618 persons

1 reference

12 December 2020

Update: Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine--United States, October 2005-February 2006

1 reference

12 December 2020

Relapsing neuropathy due to tetanus toxoid. Report of a case

1 reference

12 December 2020

Studies of HLA associations in male and female patients with Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).

1 reference

12 December 2020

Guillain-Barré Syndrome and the 1978–1979 Influenza Vaccine

1 reference

12 December 2020

An epidemiologic, clinical, and therapeutic study of childhood Guillain-Barré syndrome in Kuwait: is it related to the oral polio vaccine?

1 reference

12 December 2020

The risk of Guillain-Barré syndrome after tetanus-toxoid-containing vaccines in adults and children in the United States

1 reference

12 December 2020

Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.

1 reference

12 December 2020

Unusual features of the Guillain-Barré syndrome after rabies vaccine prepared in suckling mouse brain.

1 reference

12 December 2020

Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP).

1 reference

12 December 2020

Age-specific incidence of Guillain-Barré syndrome in Oxfordshire.

1 reference

12 December 2020

Guillain - Barre' syndrome following recombinant hepatitis B vaccine and literature review

1 reference

12 December 2020

Guillain-Barré syndrome following smallpox vaccination; report of a case

1 reference

12 December 2020

Incidence of Guillain-Barré syndrome during a nationwide oral poliovirus vaccine campaign

1 reference

12 December 2020

Two cases of Guillain-Barré syndrome and encephalitis after measles

1 reference

12 December 2020

Measles vaccination and Guillain-Barré syndrome.

1 reference

12 December 2020

Inactivated Japanese encephalitis virus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP)

1 reference

12 December 2020

Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States

1 reference

12 December 2020

Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

1 reference

12 December 2020

Understanding vaccine safety information from the Vaccine Adverse Event Reporting System

1 reference

12 December 2020

Susceptibility to Guillain-Barré syndrome is associated to polymorphisms of CD1 genes.

1 reference

12 December 2020

Guillain-Barré syndrome following immunisation with Haemophilus influenzae type b conjugate vaccine

1 reference

12 December 2020

Vaccination and autoimmunity-'vaccinosis': a dangerous liaison?

1 reference

12 December 2020

CLUSTER OF CHILDHOOD GUILLAIN-BARRÉ CASES AFTER AN ORAL POLIOVACCINE CAMPAIGN

1 reference

12 December 2020

Guillain Barre syndrome associated with hepatitis B vaccination

1 reference

12 December 2020

The Vaccine Safety Datalink project

1 reference

12 December 2020

Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP)

1 reference

12 December 2020

Guillain-Barré syndrome after combined tetanus-diphtheria toxoid vaccination

1 reference

12 December 2020

Viscerotropic and neurotropic disease following vaccination with the 17D yellow fever vaccine, ARILVAX.

1 reference

12 December 2020

HLA alleles in patients with Guillain-Barre syndrome

1 reference

12 December 2020

Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barré syndrome

1 reference

12 December 2020

Preliminary FoodNet data on the incidence of infection with pathogens transmitted commonly through food--10 states, 2007.

1 reference

12 December 2020

Challenges and controversies in immunization safety

1 reference

12 December 2020

Safety and immunogenicity of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in infancy. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group

1 reference

12 December 2020

Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP)

1 reference

12 December 2020

An epidemiologic and clinical evaluation of Guillain-Barré syndrome reported in association with the administration of swine influenza vaccines

1 reference

12 December 2020

10.2165/00002018-200932040-00005

Identifiers

DOI

1 reference

PubMed ID

19388722

Dimensions Publication ID

5 August 2017

0 references

1 reference

PubMed ID

19388722